ER-negative, basal-like breast cancers show increased expression of both PHGDH and nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of NAD+ salvage, and are sensitive to NAMPT inhibition134. This evidence concerns the gene NAMPT and breast carcinoma.